Category: basic life sciences retractions

“Apparently, the bureaucracy at Elsevier is the most cumbersome thing in the world:” Journal editor

bbrcWe recently came across a paper in Biochemical and Biophysical Research Communications, an Elsevier title, that had been temporarily removed without explanation. While we see a fair number of such opaque notices from Elsevier — and have written about why we think they’re a bad idea — we took interest in this one because the last author, Toren Finkel of the NIH, was the corresponding author of a Nature paper retracted earlier this year. (He also had two corrections on one Science paper, both of which are paywalled.)

What we learned suggests the withdrawal was completely unrelated to the Nature retraction, but also reveals a journal editor’s exasperation.

Continue reading “Apparently, the bureaucracy at Elsevier is the most cumbersome thing in the world:” Journal editor

Update: Lab head shares “painful” process that led to Molecular Cell retraction

molecular cell 14Last month, we published a guest post by Jean Hazel Mendoza about the retraction of a Molecular Cell paper for sampling errors, flawed analysis, and and miscalculation.

Mendoza heard back from Jean-François Allemand, the head of one of the labs involved. Allemand tells Retraction Watch by email that when his group tried to repeat the experiment, they suspected of “missing” or “averaging” of data points in the retracted paper: Continue reading Update: Lab head shares “painful” process that led to Molecular Cell retraction

UT-Southwestern cancer researchers up to 8 retractions

oncogeneA group at the University of Texas Southwestern led by Adi F. Gazdar that found evidence of inappropriate image manipulation in a number of their papers has retracted its seventh and eighth studies.

Here’s the notice for 2005’s “Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection,” in Oncogene: Continue reading UT-Southwestern cancer researchers up to 8 retractions

Former University of Utah researchers, one guilty of “reckless disregard,” have another paper retracted

cell metabolismA pair of University of Utah researchers who both left their posts last year following an investigation into problems with their work have had another paper retracted from Cell Metabolism.

The investigation found “reckless disregard” in papers in which Ivana De Domenico was first author. She left the university at the end of June 2013, and and her lab head, Jerry Kaplan, retired at the same time.

Here’s the notice for 2008’s “The Hepcidin-Binding Site on Ferroportin Is Evolutionarily Conserved:” Continue reading Former University of Utah researchers, one guilty of “reckless disregard,” have another paper retracted

Cancer researcher who threatened to sue Retraction Watch corrects another paper

aggarwalBharat Aggarwal, the MD Anderson researcher who has threatened to sue Retraction Watch for writing about issues in his papers, has corrected another study.

Here’s the notice for “Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors:” Continue reading Cancer researcher who threatened to sue Retraction Watch corrects another paper

De-coli: Plagiarism leads to retraction of highly cited recombinant protein paper

appliedmicrobioThe authors of a 2005 article on E. coli in Applied Microbiology and Biotechnology have lost the paper because they recombined it from previous work.

The article, titled “Strategies for efficient production of heterologous proteins in Escherichia coli,” came from a pair of biochemical engineers from the Indian Institute of Technology-Delhi, in New Delhi, India.

According to the abstract: Continue reading De-coli: Plagiarism leads to retraction of highly cited recombinant protein paper

Science retracts two papers for image manipulation

science 2014Science has retracted two papers by Frank Sauer, of the University of California, Riverside, after the university found evidence of serious image manipulation.

Here’s the notice, signed by Science editor-in-chief Marcia McNutt: Continue reading Science retracts two papers for image manipulation

Researchers repeat retracted study, republish in same journal sans first author

biol psychWe’ve been following the case of Amine Bahi, a neuroscience researcher in the United Arab Emirates who has managed something unusual in the annals of Retraction Watch: Three different retractions for three completely different reasons. One was for “legal issues,” another was for lack of IRB approval, and the third was for using RNAs from the wrong species.

Now, Bahi’s co-authors have repeated the last of those studies with the right RNAs, and have republished their paper in the same journal, Biological Psychiatry — but without Bahi.

The retraction notice for “Blockade of Protein Phosphatase 2B Activity in the Amygdala Increases Anxiety- and Depression-Like Behaviors in Mice” now includes this final paragraph: Continue reading Researchers repeat retracted study, republish in same journal sans first author

Serial fakery: Researcher found to have committed misconduct at Harvard and Oxford

harvardA former Harvard postdoc who was found guilty of faking data at Oxford as a student did the same thing at Harvard, according to the Office of Research Integrity (ORI).

We first wrote about Helen Freeman in February, when we covered a retraction in Cell Metabolism that said the UK’s Medical Research Council had found that she committed misconduct while working as a student at Oxford. Today, a Federal Register notice from the ORI reports that Freeman faked images in a manuscript submitted to Nature while she was working on federally funded grants at Harvard Medical School and Beth Israel Deaconess Medical Center.

From the ORI’s report: Continue reading Serial fakery: Researcher found to have committed misconduct at Harvard and Oxford

Diabetes researcher who says he will no longer publish now up to five retractions

toth
Cory Toth, via U Calgary

Cory Toth, the University of Calgary diabetes researcher who told us last month he would stop publishing in science following a string of inappropriate manipulations, has retracted another paper.

Here’s the notice in Brain for “Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy:” Continue reading Diabetes researcher who says he will no longer publish now up to five retractions